Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction
Clinical trial NCT03048110 · COMPLETED
Trial details
- NCT number
- NCT03048110
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-15
- Primary completion
- 2017-05-04
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.